David Lloyd: Thanks Lisa Murphy for Your Leadership
David Lloyd, Chief Executive Officer at National Heart Foundation of Australia, reposted from Lisa Murphy and Stroke Foundation on LinkedIn:
”Great colleagues and friends in complete alignment on our mission – Heart Foundation and Stroke Foundation.
Thanks Lisa Murphy for your leadership in helping to bring our two organisations closer together than ever before, to better serve our overlapping patient communities.”
Quoting Lisa Murphy‘s post:
”Stronger Together”
Quoting Stroke Foundation‘s post:
”We are proud to announce the signing of a new collaborative agreement between Stroke Foundation and Heart Foundation.
The agreement commits both organisations to continue supporting the work of the National Hypertension Taskforce, including the development of updated clinical guidelines on lipid and blood pressure management, joint projects and evidence-based position statements.
High blood pressure (hypertension) is the leading risk factor for death in Australia, with around one in three Australians living with the condition.
With only 32% of Australians currently achieving adequate blood pressure control, collaborative sector approach comes at a crucial time to improve blood pressure control to 70% by 2030 in Australia.
Achieving better management of blood pressure and lipids will mean fewer heart attacks, fewer strokes, and healthier lives for Australians across the country.
This agreement demonstrates the ongoing commitment of Stroke Foundation and Heart Foundation to work together towards a common goal: better cardiovascular health for all Australians!
(photo caption: Stroke Foundation CEO Lisa Murphy and Heart Foundation CEO David Lloyd)”
Stay updated with Hemostasis Today.
-
Mar 22, 2026, 17:21Arrigo Francesco Giuseppe Cicero: Diagnostic and Prognostic Perspectives of Glycocalyx Disruption in Pregnancy
-
Mar 22, 2026, 17:19Veronica Sanchez: Stress from Pregnancy Complications Impacts The Long-Term Cardiovascular Health
-
Mar 22, 2026, 16:21Ala Eddin Sagar: Apixaban vs Rivaroxaban on This Week in Pulmonary and Critical Care Medicine
-
Mar 22, 2026, 16:14Andre W. Bourgoyne: Anemia Management as a Comprehensive Hospital Performance Strategy
-
Mar 22, 2026, 16:03Fibrinogen-Guided Management of Postpartum Hemorrhage – Transfusion Medicine KMC Manipal
-
Mar 22, 2026, 15:48Simon Senanu: Diagnostic Significance of Target Cells in Peripheral Blood Smear
-
Mar 22, 2026, 15:43Hayley Evans: What If The Decision Support System Is Part of The Problem?
-
Mar 22, 2026, 15:29Archit Pandharipande: The Burden and Impact of Heavy Menstrual Bleeding in Adolescents with Bleeding Disorders
-
Mar 22, 2026, 15:17Mamtha Balla: Mastering the Lab and Clinical Connection in Hemostasis and Thrombosis